During the past decade, Spokane Eye Clinic conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spokane Eye Clinic" #1 sponsor was "Jaeb Center for Health Research" with 8 trials, followed by "Kodiak Sciences Inc" with 4 trials sponsored, "AqueSys, Inc." with 2 trials sponsored, "Coopervision, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spokane Eye Clinic" #1 collaborator was "National Eye Institute (NEI)" with 7 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator and "Allergan" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Spokane Eye Clinic" are "Diabetic Macular Edema" (5 trials), "Glaucoma" (2 trials), "Proliferative Diabetic Retinopathy" (2 trials), "Astigmatism" (1 trials) and "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Spokane Eye Clinic" in a lesser frequency.

Most popular intervention types in "Spokane Eye Clinic" are "Drug" (11 trials), "Other" (6 trials), "Device" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "KSI-301" (4 trials), "Aflibercept" (3 trials), "Sham Procedure" (3 trials), "Sham injection" (2 trials) and "0.3 mg intravitreal ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spokane Eye Clinic" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Spokane Eye Clinic". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Spokane Eye Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spokane Eye Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".